Treace Medical Concepts, Inc. (TMCI) financial statements and ratios from SEC XBRL: revenue $212.69M (TTM), net margin -27.7%, revenue growth 1.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $212.69M |
| Net Margin | -27.7% |
| Revenue Growth (YoY) | 1.6% |
| EPS Growth (YoY) | 3.3% |
| FCF Growth (YoY) | -39.5% |
| Price / Book | 4.26 |
| Price / Sales | 1.52 |
| FCF Yield | -4.7% |
| Altman Z-Score | 0.66 (distress) |
| Piotroski F-Score | 2/9 |
| Sector P/E (Healthcare) | 21.6 |
TMCI overview · TMCI earnings · TMCI KPIs · TMCI investor relations · TMCI ownership · TMCI peers · TMCI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.